Adolore Biotherapeutics, Inc. — Form D

Adolore Biotherapeutics, Inc. of DELRAY BEACH, FL, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-13. The offering totals $2.5M, of which $250K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-01-13
• Form: D
• Accession: 0001904161-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $250K
• Remaining: $2.3M
• Investors: 3
• Date of first sale: 2022-01-06
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-429172

Issuer

• Name: Adolore Biotherapeutics, Inc.
• CIK: 0001904161
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 13685 WHISTLER MOUNTAIN ROAD, DELRAY BEACH, FL, 33446
• Phone: 973-524-0935

Officers, directors & promoters (21)

Other filings by this issuer (2)

More

• CIK 1904161 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search